1. Home
  2. NEON vs IGC Comparison

NEON vs IGC Comparison

Compare NEON & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEON
  • IGC
  • Stock Information
  • Founded
  • NEON N/A
  • IGC 2005
  • Country
  • NEON Sweden
  • IGC United States
  • Employees
  • NEON N/A
  • IGC N/A
  • Industry
  • NEON Industrial Machinery/Components
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEON Technology
  • IGC Health Care
  • Exchange
  • NEON Nasdaq
  • IGC Nasdaq
  • Market Cap
  • NEON 37.5M
  • IGC 32.5M
  • IPO Year
  • NEON 2007
  • IGC N/A
  • Fundamental
  • Price
  • NEON $2.34
  • IGC $0.44
  • Analyst Decision
  • NEON
  • IGC Strong Buy
  • Analyst Count
  • NEON 0
  • IGC 1
  • Target Price
  • NEON N/A
  • IGC $3.25
  • AVG Volume (30 Days)
  • NEON 33.3K
  • IGC 168.6K
  • Earning Date
  • NEON 08-08-2024
  • IGC 08-08-2024
  • Dividend Yield
  • NEON N/A
  • IGC N/A
  • EPS Growth
  • NEON N/A
  • IGC N/A
  • EPS
  • NEON N/A
  • IGC N/A
  • Revenue
  • NEON $4,210,000.00
  • IGC $1,345,000.00
  • Revenue This Year
  • NEON $152.19
  • IGC $5.06
  • Revenue Next Year
  • NEON N/A
  • IGC N/A
  • P/E Ratio
  • NEON N/A
  • IGC N/A
  • Revenue Growth
  • NEON N/A
  • IGC 47.64
  • 52 Week Low
  • NEON $1.02
  • IGC $0.25
  • 52 Week High
  • NEON $4.57
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • NEON 51.90
  • IGC 49.96
  • Support Level
  • NEON $2.16
  • IGC $0.40
  • Resistance Level
  • NEON $2.57
  • IGC $0.45
  • Average True Range (ATR)
  • NEON 0.13
  • IGC 0.03
  • MACD
  • NEON 0.02
  • IGC 0.00
  • Stochastic Oscillator
  • NEON 58.18
  • IGC 47.89

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in United States, Japan, South Korea, Germany, Switzerland, China, France, Sweden and Others. It derives maximum revenue from United States.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: